Healthcare provider profile · identity verified

Melissa Hayden, M.D.

Internal Medicine · PORTLAND, OR · NPI 1295025518

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	447	140
Levothyroxine Sodium	Levothyroxine Sodium	402	110
Amlodipine Besylate	Amlodipine Besylate	311	93
Losartan Potassium	Losartan Potassium	282	88
Lisinopril	Lisinopril	279	84
Albuterol Sulfate Hfa	Albuterol Sulfate	213	71
Trazodone Hcl	Trazodone Hcl	213	62
Rosuvastatin Calcium	Rosuvastatin Calcium	202	62
Oxycodone Hcl	Oxycodone Hcl	197	39
Gabapentin	Gabapentin	186	54
Metformin Hcl	Metformin Hcl	170	52
Atenolol	Atenolol	166	46
Simvastatin	Simvastatin	153	40
Fluoxetine Hcl	Fluoxetine Hcl	140	34
Alendronate Sodium	Alendronate Sodium	134	46
Pantoprazole Sodium	Pantoprazole Sodium	134	53
Potassium Chloride	Potassium Chloride	128	48
Metoprolol Succinate	Metoprolol Succinate	124	43
Pradaxa	Dabigatran Etexilate Mesylate	122	41
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	116	35
Mirtazapine	Mirtazapine	109	22
Sertraline Hcl	Sertraline Hcl	108	31
Metoprolol Tartrate	Metoprolol Tartrate	104	36
Duloxetine Hcl	Duloxetine Hcl	98	24
Ozempic	Semaglutide	98	11
Bupropion Xl	Bupropion Hcl	93	29
Omeprazole	Omeprazole	90	33
Glipizide	Glipizide	85	27
Tamsulosin Hcl	Tamsulosin Hcl	83	31
Metformin Hcl Er	Metformin Hcl	82	32
Spironolactone	Spironolactone	78	28
Pravastatin Sodium	Pravastatin Sodium	76	23
Furosemide	Furosemide	69	33
Estradiol	Estradiol	68	30
Warfarin Sodium	Warfarin Sodium	68	17
Clopidogrel	Clopidogrel Bisulfate	67	19
Ondansetron Odt	Ondansetron	66	17
Buspirone Hcl	Buspirone Hcl	65	18
Carvedilol	Carvedilol	65	21
Prednisone	Prednisone	65	29
Tramadol Hcl	Tramadol Hcl	65	19
Wixela Inhub	Fluticasone Propion/Salmeterol	65	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	63	22
Spiriva Respimat	Tiotropium Bromide	62	19
Lorazepam	Lorazepam	59	20
Citalopram Hbr	Citalopram Hydrobromide	57	17
Alvesco	Ciclesonide	56	24
Escitalopram Oxalate	Escitalopram Oxalate	55	14
Hydrochlorothiazide	Hydrochlorothiazide	55	21
Famotidine	Famotidine	54	13
Fluticasone Propionate	Fluticasone Propionate	52	21
Venlafaxine Hcl Er	Venlafaxine Hcl	48	12
Allopurinol	Allopurinol	46	13
Donepezil Hcl	Donepezil Hcl	46	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	46	15
Lovastatin	Lovastatin	45	13
Doxycycline Monohydrate	Doxycycline Monohydrate	44	29
Humulin N	Insulin Nph Human Isophane	43	13
Jardiance	Empagliflozin	42	13
Meloxicam	Meloxicam	39	19
Montelukast Sodium	Montelukast Sodium	37	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	37	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	36	13
Bupropion Hcl Sr	Bupropion Hcl	34	suppressed
Sure Comfort Pen Needle	Pen Needle, Diabetic	33	11
Propranolol Hcl	Propranolol Hcl	31	11
Sumatriptan Succinate	Sumatriptan Succinate	30	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Doxepin Hcl	Doxepin Hcl	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	11
Eliquis	Apixaban	27	suppressed
Baclofen	Baclofen	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Valacyclovir	Valacyclovir Hcl	26	suppressed
Terazosin Hcl	Terazosin Hcl	25	suppressed
Hydrocortisone	Hydrocortisone	24	15
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	24	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	22
Pioglitazone Hcl	Pioglitazone Hcl	24	suppressed
Victoza 3-Pak	Liraglutide	24	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	23	suppressed
Liraglutide	Liraglutide	22	suppressed
Cephalexin	Cephalexin	21	13
Clonazepam	Clonazepam	21	suppressed
Humulin R	Insulin Regular, Human	20	suppressed
Trospium Chloride	Trospium Chloride	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Clonidine Hcl	Clonidine Hcl	17	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	17	suppressed
Finasteride	Finasteride	17	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	17	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	16	suppressed
Fenofibrate	Fenofibrate	16	suppressed
Hydralazine Hcl	Hydralazine Hcl	16	suppressed
Nitroglycerin	Nitroglycerin	16	11
Torsemide	Torsemide	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Alprazolam	Alprazolam	15	suppressed
Morphine Sulfate Er	Morphine Sulfate	15	suppressed
Nystatin	Nystatin	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Creon	Lipase/Protease/Amylase	14	suppressed
Metronidazole	Metronidazole	14	suppressed
Morphine Sulfate	Morphine Sulfate	14	suppressed
Pregabalin	Pregabalin	14	suppressed
Victoza 2-Pak	Liraglutide	14	12
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	13
Carbamazepine	Carbamazepine	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Celecoxib	Celecoxib	12	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Fluoridex	Fluoride (Sodium)	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	12	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Topiramate	Topiramate	12	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	11	11
Atomoxetine Hcl	Atomoxetine Hcl	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	11
Lansoprazole	Lansoprazole	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error